Our results support that CMV reactivation, while influencing immune reconstitution of CMV-CTL, may as well affects WT1 specific immune response by increasing T cell activation, thus potentially contributing to the remission/relapse of AML after transplantation. This evidence concerns the gene WT1 and acute myeloid leukemia.